Provided by

Decontamination and Sterilisation (CSSD) Conference

Locally Accredited

Overview

CSSD operates 7 days a week, 24 hours a day. It aims at assuming total responsibility for processing hospital items, thereby assuring that all of these items receive the same degree of cleaning and sterilisation. In addition, the professional expertise employed in CSSD is not only to manage efficiency, economy and patient safety, but also to maintain consistent high standards for sterilisation technique and decontamination process quality throughout the hospital.

The 12th edition of the Decontamination and Sterilisation Conference is a three-day scientific meeting tailored to address basic but comprehensive CSSD procedures used in the healthcare industry in the Middle East. The conference explores practical application of basic scientific knowledge, how and why specific cleaning and sterilisation methods are used in particular applications, how the methods are validated, and the strengths and weaknesses of different sterilisation methods. 

Benefits of attending:

  • Explore advances in decontamination and sterilisation procedures to provide a safe environment for patients and staff
  • Review basics on microbial destruction, sterility sampling, sterility assurance, and sterilisation cycle development to improve infection control
  • Discover trends in microbial monitoring techniques for provision of better patient care
  • Discuss new methods in inventory of supplies and equipment to deliver quicker and accurate services
  • Appraise new architectural designs of CSSD to decrease risk of contamination, increase efficiency and reduce cost of handling instruments
  • Identify sources of sterilisation failures and develop risk management to control errors

Key topics:

  • Achievement report 2017 – Clinical compliance with CSSD quality
  • Effective design of the decontamination area
  • Staff engagement
  • Updates on cleaning standard
  • Validation of steriliser processes
  • Importance of logistics
  • Monitoring of the decontamination environment
  • Sterilisation practices and infection control
  • Advances in eliminating infection risk reservoirs

Who shall attend:

  • CSSD Managers
  • CSSD Supervisors
  • CSSD Technicians
  • Head of CSSD
  • Sterile Service Managers
  • Sterile Processing Technicians
  • Hospital Decontamination Coordinators
  • Decontamination & Sterilisation Personnel
  • Operating Theatre Personnel
  • Infection Control Nurse
  • Dental Technicians
  • Endoscope Decontamination Technician/Nurses
  • Infection Prevention & Control Personnel
  • Critical Care Personnel

Local Chair:
Jason David Unger,
Manager, Sterile Processing, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

 

DAY 1: Tuesday, 24 October 2017
09:00 Opening remarks by Conference Chair:
Jason David Unger, Manager, Sterile Processing, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
SESSION 1: CHALLENGES AND ERRORS
Moderator: Jason David Unger, Manager, Sterile Processing, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
09:15 Challenges facing CSSD technicians
Ahmed Baggashi, Head of CSSD & IC Education Team, Jeddah Health Affairs, Jeddha, KSA
10:00 CSSD culture: Discussing errors
Tom Pereboom, CSSD Manager, MC Groep, Lelystad, The Netherlands
10:45 Coffee Break
SESSION 2: STRATEGIC PLANNING
Moderator: Pete Newson, Director, Global Consumables, Getinge International, Sussex, UK
11:15

Single use vs reusable instruments
Tracey Scott, Executive Director of Infection Prevention and Control Department at the Ministry of National Guard, King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA

12:00

Outsourcing CSSD
Hannah McMahon, Decontamination Services Manager, Zehnacker Ireland Healthcare - Cappagh National Orthopaedic Hospital, Dublin, Ireland

12:45 Lunch Break
SESSION 3: DISINFECTION
Moderator: Jason David Unger, Manager, Sterile Processing, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
14:00

Disinfectants in CSSD
Anthony Pellicci, Global Director - Consumables, Getinge Middle East and Africa, Dubai, UAE

14:45

Chemical disinfection use
Christina Bradley, Laboratory Manager HIRL, Clinical Microbiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

15:30

Coffee Break

SESSION 4: VALIDATION
Moderator: Christina Bradley, Laboratory Manager HIRL, Clinical Microbiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
16:00

Validation of cleaning
Lionel Pineau, General and Scientific Director, Biotech-Germande, Marseille, France

16:45

5 moments of CSSD hand hygiene
Assaf Almalki, Head, Anaesthesia, Fahad Medical City, Riyadh, KSA

17:30 Close of Day 1 Conference
DAY 2: Wednesday, 25 October 2017
09:00 Opening remarks by Conference Chair:
Jason David Unger, Manager, Sterile Processing, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
SESSION 5: FLEXIBLE ENDOSCOPES
Moderator: Jason David Unger, Manager, Sterile Processing, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
09:15 Endoscopy: Challenges, guidelines, best practices and trends
Cynthia Spry, Independent Clinical Consultant, New York, USA
10:00 Harmonising endoscopy standards in the Middle East
Ahmed Ghatwary, Management Representative, SteriGMS, Ghatwary Medical Supply(GMS), Alexandria, Egypt
10:45 Coffee Break
SESSION 6: HIGH LEVEL DISINFECTION
Moderator: Pete Newson, Director, Global Consumables, Getinge International, Sussex, UK
11:15

Biofilms and endoscopes
Lionel Pineau, General and Scientific Director, Biotech-Germande, Marseille, France

12:00

Decontamination of intra-cavity probes
Christina Bradley, Laboratory Manager HIRL, Clinical Microbiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

12:45 Lunch Break
SESSION 7: REPROCESSING AND TRACKING
Moderator: Ahmed Ghatwary, Management Representative, SteriGMS, Ghatwary Medical Supply(GMS), Alexandria, Egypt
14:00

LMA reprocessing
Tracey Hannon, CSSD Manager and Decontamination Lead, The Bon Secours Dublin - Bon Secours Hospital, Dublin, Ireland

14:45

Benefits of GS1 Coding
Hannah McMahon, Decontamination Services Manager, Zehnacker Ireland Healthcare - Cappagh National Orthopaedic Hospital, Dublin, Ireland

15:30

Coffee Break

SESSION 8: STERILISATION AND PACKAGING
Moderator: Georgia Alevizopoulou, Senior Clinical and Education Manager, Steris Europe, Middle East and Africa, Infection Prevention Technologies, Athens, Greece
16:00

Steam plant design
Tahseen Mousa, Sterile Processing Technician, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

16:45

Factors impacting sterilisation
Ahmed Baggashi, Head of CSSD & IC Education Team, Jeddah Health Affairs, Jeddha, KSA

17:30 Close of Day 2 Conference
DAY 3: Thursday, 26 October 2017
09:00 Opening remarks by Conference Chair:
Jason David Unger, Manager, Sterile Processing, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
SESSION 9: EDUCATION
Moderator: Jason David Unger, Manager, Sterile Processing, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
09:15 Practical instrument training
Zahra Hashim, CSSD Technician, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
10:00 CSSD education in the Netherlands
Tom Pereboom, CSSD Manager, MC Groep, Lelystad, The Netherlands
10:45 Coffee Break
SESSION 10: QUALITY
Moderator: Ahmed Baggashi, Infection Control Educator, CSSD Manager, King Fahad Hospital, Ministry of Health Saudi Arabia, Jeddah, KSA
11:15

Improving patient safety, a critical priority
Cynthia Spry, Independent Clinical Consultant, New York, USA

12:00

Troubleshooting quality problems
Georgia Alevizopoulou, Senior Clinical & Education Manager, Steris Europe, Middle East and Africa, Infection Prevention Technologies, Athens, Greece

12:45 Lunch Break
SESSION 11: QUIZ
Moderators: Pete Newson, Management Representative, SteriGMS, Ghatwary Medical Supply(GMS), Alexandria, Egypt
Jason David Unger,
Manager, Sterile Processing, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
14:00

Interactive test to reinforce conference learning

15:30

Coffee Break

SESSION 12: STANDARDS DEBATE / PANEL DISCUSSION
Moderator: Georgia Alevizopoulou, Senior Clinical and Education Manager, Steris Europe, Middle East and Africa, Infection Prevention Technologies, Athens, Greece
16:00

Which standards should we follow?

16:45

Closing remarks by Conference Chair

17:30 End of Conference

Jason David Unger

Manager, Sterile Processing

Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE


Ahmed Baggashi

Head of CSSD & IC Education Team
Jeddah Health Affairs, Jeddha, KSA


Ahmed Ghatwary

Management Representative

SteriGMS, Ghatwary Medical Supply(GMS), Alexandria, Egypt


Anthony Pellicci

Global Director - Consumables

Getinge Middle East & Africa, Dubai, UAE


Assaf Almalki

Head, Anaesthesia

King Fahad Medical City, Riyadh, KSA


Benjamin Mietz

Global Product Manager

Getinge, Mersin, Turkey


Christina Bradley

Laboratory Manager HIRL, Clinical Microbiology

University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK


Cynthia Spry

Independent Clinical Consultant

New York, USA


Georgia Alevizopouloui

Senior Clinical & Education Manager

Steris Europe, Middle East and Africa, Infection Prevention Technologies, Athens, Greece


Hannah McMahon

Decontamination Services Manager

Zehnacker Ireland Healthcare - Cappagh National Orthopaedic Hospital, Dublin, Ireland


Pete Newson

Director, Global Consumables,

Getinge International, Sussex, UK


Tahseen Mousa

Sterile Processing Technician

Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE


Tom Pereboom

CSSD Manager

MC Groep, Lelystad, The Netherlands


Tracey Hannon

CSSD Manager & Decontamination Lead

The Bon Secours Dublin - Bon Secours Hospital, Dublin, Ireland


Tracey Scott

Decontamination Business Development Manager

Zehnacker Ireland Healthcare, Leinster, Ireland


Zahra Hashim

CSSD Technician

Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE


Provided by

Accreditation Statement:

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for the maximum of 16.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.